第一单位：
School of Cancer Science, University of Glasgow, Glasgow, UK; Department of Head and Neck Oncology and Surgery, The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. Electronic address: conchita.vens@glasgow.ac.uk.
作者：
C,Vens [1]
;
P,van Luijk [2]
;
R I,Vogelius [3]
;
I,El Naqa [4]
;
L,Humbert-Vidan [5]
;
C,von Neubeck [6]
;
N,Gomez-Roman [7]
;
E,Bahn [8]
;
L,Brualla [9]
;
T T,Böhlen [10]
;
S,Ecker [11]
;
R,Koch [6]
;
A,Handeland [12]
;
S,Pereira [13]
;
L,Possenti [14]
;
T,Rancati [14]
;
D,Todor [15]
;
B,Vanderstraeten [16]
;
M,Van Heerden [17]
;
W,Ullrich [18]
;
M,Jackson [19]
;
M,Alber [20]
;
L,Marignol [21]
;
ESTRO DREAM team
作者单位：
School of Cancer Science, University of Glasgow, Glasgow, UK; Department of Head and Neck Oncology and Surgery, The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. Electronic address: conchita.vens@glasgow.ac.uk.
[1]
Department of Biomedical Sciences of Cells and Systems, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands; Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. Electronic address: p.van.luijk@umcg.nl.
[2]
Department of Oncology, Rigshospitalet, Copenhagen, Denmark; Faculty of Health and Medical Sciences, University of Copenhagen, Denmark. Electronic address: ivan.richter.vogelius@regionh.dk.
[3]
Department of Radiation Oncology, University of Michigan, Ann Arbor, MI 48103, United States. Electronic address: issam.elnaqa@moffitt.org.
[4]
University of Texas MD Anderson Cancer Centre, Houston, TX, United States; Department of MedicalPhysics, Guy's and St Thomas' NHS Foundation Trust, London, UK; School of Cancer and Pharmaceutical Sciences, Comprehensive Cancer Centre, King's College London, London, UK.
[5]
Department of Particle Therapy, University Hospital Essen, University of Duisburg-Essen, Essen 45147, Germany.
[6]
Strathclyde Institute of Phrmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK.
[7]
Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany; National Center for Tumor Diseases (NCT), Heidelberg, Germany; Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
[8]
West German Proton Therapy Centre Essen (WPE), Essen, Germany; Faculty of Medicine, University of Duisburg-Essen, Germany.
[9]
Institute of Radiation Physics, Lausanne University Hospital and Lausanne University, Lausanne, Switzerland.
[10]
Department of Radiation Oncology, Medical University of Wien, Austria.
[11]
Department of Oncology and Medical Physics, Haukeland University Hospital, Bergen, Norway; Department of Physics and Technology, University of Bergen, Bergen, Norway.
[12]
Neolys Diagnostics, 7 Allée de l'Europe, 67960 Entzheim, France.
[13]
Data Science Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
[14]
Department of Radiation Oncology, Virginia Commonwealth University, United States.
[15]
Department of Radiotherapy-Oncology, Ghent University Hospital, Gent, Belgium; Department of Human Structure and Repair, Ghent University, Gent, Belgium.
[16]
Center for Proton Therapy, Paul Scherrer Institute, Villigen, Switzerland.
[17]
Brinlab AG, München, Germany.
[18]
School of Cancer Science, University of Glasgow, Glasgow, UK.
[19]
Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany.
[20]
Applied Radiation Therapy Trinity (ARTT), Discipline of Radiation Therapy, School of Medicine, Trinity St. James's Cancer Institute, Trinity College Dublin, University of Dublin, Dublin, Ireland.
[21]
DOI
10.1016/j.radonc.2024.110277
PMID
38670264
发布时间
2024-09-09
换一批
